{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:08:19Z","timestamp":1788815299930,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["JJQN2023-02"],"award-info":[{"award-number":["JJQN2023-02"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373041"],"award-info":[{"award-number":["82373041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014418","name":"Harbin Medical University Cancer Hospital","doi-asserted-by":"publisher","award":["PDYS2024-01"],"award-info":[{"award-number":["PDYS2024-01"]}],"id":[{"id":"10.13039\/100014418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118345","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:48:59Z","timestamp":1786722539000},"page":"118345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["FTO-mediated m6A demethylation of SNHG9 enhances PINK1-dependent mitophagy and reverses cisplatin resistance via nuclear EZH2 ubiquitination"],"prefix":"10.1016","volume":"253","author":[{"given":"Zihan","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-763X","authenticated-orcid":false,"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118345_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2026.118345_b0010","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202404609","article-title":"m6A-modified SNRPA controls alternative splicing of ERCC1 exon 8 to induce cisplatin resistance in lung adenocarcinoma","volume":"11","author":"Fan","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bcp.2026.118345_b0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jhep.2025.03.028","article-title":"Cisplatin-induced disruption of mitochondrial divisome leads to enhanced cisplatin resistance in cholangiocarcinoma","volume":"83","author":"Lv","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2026.118345_b0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12943-022-01680-z","article-title":"Biological and pharmacological roles of m6A modifications in cancer drug resistance","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118345_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-023-00386-2","article-title":"Emerging roles of m6A RNA modification in cancer therapeutic resistance","volume":"12","author":"Liu","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118345_b0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cell.2020.05.012","article-title":"A unified model for the function of YTHDF proteins in regulating m6A-modified mRNA","volume":"181","author":"Zaccara","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118345_b0035","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118345_b0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m6A modification in cancer","volume":"20","author":"Deng","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118345_b0045","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.21037\/jtd-23-187","article-title":"YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer","volume":"15","author":"Wang","year":"2023","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.bcp.2026.118345_b0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118345_b0055","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s12276-025-01603-0","article-title":"Noncanonical association of EZH2 with E2F1 promotes tumor proliferation through chromatin remodeling","volume":"57","author":"Yoo","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2026.118345_b0060","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241306026","article-title":"Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities","volume":"17","author":"Wozniak","year":"2025","journal-title":"Ther Adv Med Oncol."},{"key":"10.1016\/j.bcp.2026.118345_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118106","article-title":"Recent update on the development of EZH2 inhibitors and degraders for cancer therapy","volume":"299","author":"Tang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118345_b0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13045-021-01212-0","article-title":"LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2","volume":"14","author":"Lu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118345_b0075","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/s41467-021-23071-6","article-title":"Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance","volume":"12","author":"Giddings","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118345_b0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jb\/mvaf079","article-title":"Ubiquitin signaling in PINK1\/Parkin-dependent mitophagy","volume":"179","author":"Okatsu","year":"2026","journal-title":"J. Biochem."},{"key":"10.1016\/j.bcp.2026.118345_b0085","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/srep01002","article-title":"PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy","volume":"2","author":"Shiba-Fukushima","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118345_b0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1126\/science.adu6445","article-title":"Structure of human PINK1 at a mitochondrial TOM-VDAC array","volume":"388","author":"Callegari","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118345_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118345_b0100","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/17568919.2024.2380245","article-title":"Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors","volume":"16","author":"Ren","year":"2024","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2026.118345_b0105","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/biom14080932","article-title":"The RNA demethylases ALKBH5 and FTO regulate the translation of ATF4 mRNA in sorafenib-treated hepatocarcinoma cells","volume":"14","author":"Adjibade","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.118345_b0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","article-title":"Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management","volume":"15","author":"Jin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2026.118345_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202400695","article-title":"m6A-mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8+ T cells and phagocytosis of macrophages","volume":"11","author":"Xi","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bcp.2026.118345_b0120","article-title":"Long non-coding RNA IGFRIL couples with PTBP1 to destabilize IGFBP3 mRNA to promote the IGF1R-AKT-mTOR axis and hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bcp.2026.118345_b0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/BST20230574","article-title":"RNA m6A modification, signals for degradation or stabilisation?","volume":"52","author":"Wei","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bcp.2026.118345_b0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00441-023-03834-x","article-title":"lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2","volume":"394","author":"Yang","year":"2023","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bcp.2026.118345_b0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12859-023-05271-7","article-title":"EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates","volume":"24","author":"Fan","year":"2023","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.bcp.2026.118345_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116154","article-title":"Discovery of a novel, highly potent EZH2 PROTAC degrader for targeting non-canonical oncogenic functions of EZH2","volume":"267","author":"Velez","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118345_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109553","article-title":"Impaired mitophagy causes mitochondrial DNA leakage and STING activation in ultraviolet B-irradiated human keratinocytes HaCaT","volume":"737","author":"Li","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2026.118345_b0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bcp.2026.118345_b0155","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00109-022-02268-2","article-title":"Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin","volume":"100","author":"Gong","year":"2022","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bcp.2026.118345_b0160","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185149","article-title":"KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer","volume":"135","author":"Yu","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118345_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31296","article-title":"FTO blocks RNA translational activity via the loss of N6-methyladenosine methylation at 5\u2032 UTR regulated by RBM5 in cisplatin-resistant NSCLC","volume":"239","author":"Li","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2026.118345_b0170","article-title":"The lncRNA-m6A axis in cancer: a bidirectional regulatory network in tumor progression and therapeutic resistance","author":"Wang","year":"2026","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118345_b0175","article-title":"Epitranscriptomic RNA m6A modification in cancer therapy resistance: challenges and unrealized opportunities","volume":"12","author":"Uddin","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bcp.2026.118345_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.778582","article-title":"Non-coding RNA m6A modification in cancer: mechanisms and therapeutic targets","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.118345_b0185","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1158\/0008-5472.CAN-19-3626","article-title":"Long noncoding RNA TINCR-mediated regulation of acetyl-CoA metabolism promotes nasopharyngeal carcinoma progression and chemoresistance","volume":"80","author":"Zheng","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2026.118345_b0190","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.scib.2021.01.027","article-title":"MAFG-AS1\/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis","volume":"66","author":"Xiang","year":"2021","journal-title":"Sci. Bull."},{"key":"10.1016\/j.bcp.2026.118345_b0195","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00432-022-04134-7","article-title":"Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression","volume":"148","author":"Liu","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118345_b0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118345_b0205","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/cas.14840","article-title":"The noncanonical role of EZH2 in cancer","volume":"112","author":"Huang","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2026.118345_b0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.118345_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104972","article-title":"Regulation of EZH2 protein stability: new mechanisms, roles in tumorigenesis, and roads to the clinic","volume":"100","author":"Guo","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2026.118345_b0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13148-023-01606-6","article-title":"EZH2 K63-polyubiquitination affecting migration in extranodal natural killer\/T-cell lymphoma","volume":"15","author":"Li","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bcp.2026.118345_b0225","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118345_b0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12860-026-00566-y","article-title":"Mitochondrial HMGCS1 mediates cisplatin resistance in cervical cancer through regulation of mitochondrial transcription","volume":"27","author":"Yang","year":"2026","journal-title":"BMC Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118345_b0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fcell.2020.00270","article-title":"Mitochondrial quality control governed by ubiquitin","volume":"8","author":"Ravanelli","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.118345_b0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41586-021-04340-2","article-title":"Activation mechanism of PINK1","volume":"602","author":"Gan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118345_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101385","article-title":"Mitophagy: a key regulator of radiotherapy resistance in the tumor immune microenvironment","volume":"105","author":"Xia","year":"2025","journal-title":"Mol. Aspects Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:20:01Z","timestamp":1788812401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":49,"alternative-id":["S0006295226006842"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118345","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FTO-mediated m6A demethylation of SNHG9 enhances PINK1-dependent mitophagy and reverses cisplatin resistance via nuclear EZH2 ubiquitination","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118345"}}